RxDoctor Payments Data

Anne Gillis, MD

General Practice · Maysville, KYNPI 1225006869

Payments from drug & device makers

$2,310in general payments, 2019–2025

Across 170 payments — averaging $13.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$842
  • GSK$157
  • Novo Nordisk$146
  • Corcept Therapeutics$130
  • Amgen$126
  • Esperion Therapeutics, Inc.$118
  • plus $791 from 23 others

What the payments were for

  • Food & beverage$2,310100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,310 in reported general payments places this provider in the 90th percentile of 1,155 general practice providers in Kentucky.

See all general practice providers in Kentucky

Medicare billing

Part B allowed, 2024
$632
Medicare patients
31
Services billed
48

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin39$48,967
JanuviaSitagliptin Phosphate38$47,254
OzempicSemaglutide45$42,793
TrulicityDulaglutide31$30,560
Breztri AerosphereBudesonide/Glycopyr/Formoterol39$28,741
FarxigaDapagliflozin Propanediol12$16,711
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$15,924
XareltoRivaroxaban11$13,293
MounjaroTirzepatide13$13,009
Breo ElliptaFluticasone/Vilanterol18$10,230
EliquisApixaban14$8,797
Novolog FlexpenInsulin Aspart19$7,829
Lantus SolostarInsulin Glargine,hum.Rec.Anlog43$7,544
Repatha SureclickEvolocumab11$6,201
SymbicortBudesonide/Formoterol Fumarate15$4,603

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$65$50,05566 claims
MerckJanuvia$24$47,25438 claims
Lilly USA, LLCTrulicity, Mounjaro$41$43,56944 claims
Novo NordiskOzempic$146$42,79345 claims
GSKTrelegy Ellipta, Breo Ellipta$157$26,15432 claims
PfizerEliquis$80$8,79714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,155 general practice providers in Kentucky.

Other general practice in Maysville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →